TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Emmanuel S Antonarakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.